[Pathophysiology of bone loss in rheumatic diseases--do bone markers help in monitoring?].
Hein
G E
GE
Klinik für Innere Medizin IV Friedrich-Schiller-Universität 07740 Jena, Germany. gert.hein@med.uni-jena.de
D001172:Arthritis, Rheumatoid / Q000503:physiopathology*; D015519:Bone Density / Q000502:physiology*; D002352:Carrier Proteins / Q000097:blood*; D016207:Cytokines / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008562:Membrane Glycoproteins / Q000097:blood*; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010024:Osteoporosis / Q000175:diagnosis / Q000503:physiopathology*; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor
D002352:Carrier Proteins; D016207:Cytokines; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human